Combined Treatment With Fresh Frozen Plasma and Rituximab (Mabthera) in Patients With Advanced Refractory Chronic Lymphocytic Leukemia

Name: Combined Treatment With Fresh Frozen Plasma and Rituximab (Mabthera) in Patients With Advanced Refractory Chronic Lymphocytic Leukemia
Published: 2009
License: Public Domain

Wolfson Medical Center · 2009

ClinicalTrials.gov · Datasets · License: Public Domain · 2009

Open Source ↗

complement response

advanced refractory chronic lymphocytic leukemia, rituximab, mabthera, ffp, fresh frozen plasma, cll, complement, response, overall response rate of ffp+rituximab combined therapy, analysis of complement activation pathways prior to, during and, after the study treatment., time to disease progression

This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Record · ID 845833
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.